Inhibition of ATP-sensitive potassium channels in cardiac myocytes by the novel class III antiarrhythmic agent MS-551.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Acta Pharmacologica et Toxicologica

• Publication date

  1995-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1600-0773.1995.TB01915.XPMID 8532614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular electrophysiological effects of MS‐551, a new class III antiarrhythmic agent

  1995cited by this paper
• JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements.

  1994cited by this paper
• Effects of disopyramide and flecainide on the kinetics of inward rectifier potassium channels in rabbit heart muscle

  1994cited by this paper
• Antiarrhythmic Agent, MS‐551, Protects Against Pinacidil + Hypoxia‐Induced Ventricular Fibrillation in Langendorff‐Perfused Rabbit Isolated Heart

  1994cited by this paper
• Effects of MS‐551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes

  1993cited by this paper
• Single delayed rectifier channels in the membrane of rabbit ventricular myocytes.

  1993cited by this paper
• Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.

  1992cited by this paper
• Verapamil diminishes action potential changes during metabolic inhibition by blocking ATP-regulated potassium currents.

  1992cited by this paper
• Pharmacological Evidence for a Role of ATP‐Dependent Potassium Channels in Myocardial Stunning

  1992cited by this paper
• Development of Class III Antiarrhythmic Agents

  1992cited by this paper
• RP 58866 and Its Active Enantiomer RP 62719 (Terikalant): Blockers of the Inward Rectifier K+ Current Acting as Pure Class III Antiarrhythmic Agents

  1992cited by this paper
• Role of ATP dependent potassium channels in myocardial ischaemia.

  1992cited by this paper
• Essential role of nucleotide diphosphates in nicorandil-mediated activation of cardiac ATP-sensitive K+ channel. A comparison with pinacidil and lemakalim.

  1991cited by this paper
• ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.

  1991cited by this paper
• The ATP-sensitive K+ channel.

  1991cited by this paper
• ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction.

  1991cited by this paper
• Effects of ATP‐sensitive K+ channel blockers on the action potential shortening in hypoxic and ischaemic myocardium

  1991cited by this paper
• Effect of quinidine and tetrandine on BaCl2-induced arrhythmia

  1990cited by this paper
• Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

  1990cited by this paper
• Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias.

  1990cited by this paper
• Interrelation between pinacidil and intracellular ATP concentrations on activation of the ATP-sensitive K+ current in guinea pig ventricular myocytes.

  1990cited by this paper
• Multiple actions of pinacidil on adenosine triphosphate‐sensitive potassium channels in guinea‐pig ventricular myocytes.

  1990cited by this paper
• Is Class III antiarrhythmic activity important?

  1990cited by this paper
• Quinidine blocks adenosine 5'-triphosphate-sensitive potassium channels in heart.

  1990cited by this paper
• Antiarrhythmic effect and haemodynamic properties of MS-551, a new class III antiarrhythmic agent, in anaesthetized dogs

  1990cited by this paper
• Inhibition of ATP-Sensitive Potassium Channels of Adult Rat Heart Cells by Antiarrhythmic Drugs

  1989cited by this paper
• Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts.

  1989cited by this paper
• Modification of class III anti-arrhythmic activity in abnormal myocardium.

  1988cited by this paper
• Sampling, log binning, fitting, and plotting durations of open and shut intervals from single channels and the effects of noise

  1987cited by this paper
• ATP-regulated K+ channels in cardiac muscle

  1983cited by this paper
• Ionic basis of electrical activity in cardiac tissues.

  1978cited by this paper

• Determination of Concentration of Nifekalant in Human Plasma by HPLC Method and Investigation of Its Pharmacokinetics

  2016cites this paper
• Comparison of the Effects of Na+ and K+ Channel Blockers on the Electrophysiological Properties of the Pulmonary Veins in Patients with Atrial Fibrillation

  2010cites this paper
• Can nifekalant hydrochloride be used as a first-line drug for cardiopulmonary arrest (CPA)? : comparative study of out-of-hospital CPA with acidosis and in-hospital CPA without acidosis.

  2006cites this paper
• Destabilization and early termination of spiral-wave reentry by a class III antiarrhythmic agent, nifekalant, in a perfused two-dimensional layer of rabbit ventricular myocardium.

  2006cites this paper
• Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia in patients with ischemic heart disease.

  2005cites this paper
• Combined effects of nifekalant and lidocaine on the spiral-type re-entry in a perfused 2-dimensional layer of rabbit ventricular myocardium.

  2005cites this paper
• Electrophysiological effects of nifekalant and sotalol

  2005cites this paper
• Nifekalant hydrochloride suppresses severe electrical storm in patients with malignant ventricular tachyarrhythmias.

  2005cites this paper
• Electropharmacological and Proarrhythmic Effects of a Class III Antiarrhythmic Drug Nifekalant Hydrochloride Assessed Using the In Vivo Canine Models

  2004cites this paper
• Effects of Intravenous Nifekalant, A Class III Antiarrhythmic Drug, on Atrial Vulnerability Parameters in Patients with Paroxysmal Atrial Fibrillation

  2004cites this paper
• Nifekalant hydrochloride, a novel class III antiarrhythmic agent, suppressed postoperative recurrent ventricular tachycardia in a patient undergoing coronary artery bypass grafting and the Dor approach.

  2003cites this paper
• K(+) channels as therapeutic drug targets.

  2002cites this paper
• Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action.

  2002cites this paper
• Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction.

  2001cites this paper
• Antiarrhythmic drugs and cardiac ion channels: mechanisms of action.

  1998cites this paper
• Concentration-dependent block of sodium current in guinea pig ventricular myocytes by a class III antiarrhythmic agent, MS-551.

  1998cites this paper
• Electropharmacology of Nifekalant, a New Class III Antiarrhythmic Drug

  1998cites this paper
• Effect of a class III anti-arrthythmic agent MS-551 on Na+ current in guinea pig ventricular myocyte.

  1998cites this paper
• MS‐551 and KCB‐328, two class III drugs aggravated adrenaline‐induced arrhythmias

  1998influential citation
• Antiarrhythmic agents: Current status and perspectives

  1997cites this paper
• The Novel Class III Antiarrhythmic Agent MS-551 Blocks the Cardiac Inward Rectifier With Greater Potency Than Sotalol or E-4031: Possible Relevance to Reverse Use Dependence

  1997cites this paper
• Effect of Dofetilide and d-Sotalol on the ATP-Sensitive Potassium Channel of Rabbit Ventricular Myocytes

  1996cites this paper
• IK independent class III actions of MS‐551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats

  1996cites this paper
• Äîñë3äæåííÿ êàðä3îïðîòåêòîðíèõ åôåêò3â íîâîãî ôòîðì3ñíîãî àêòèâàòîðà ÀÒÔ-çàëåæíèõ êàë3oâèõ êàíàë3â

  year unknowncites this paper